Litigation Details for Takeda Pharmaceuticals U.S.A. v. Hikma Americas Inc. (Fed. Cir. 2014)
✉ Email this page to a colleague
Takeda Pharmaceuticals U.S.A. v. Hikma Americas Inc. (Fed. Cir. 2014)
| Docket | 15-1139 | Date Filed | 2014-11-07 |
| Court | Court of Appeals for the Federal Circuit | Date Terminated | |
| Cause | Assigned To | ||
| Jury Demand | Referred To | ||
| Parties | HIKMA AMERICAS INC. | ||
| Patents | 6,037,157; 7,601,758; 7,619,004; 7,820,681; 7,906,519; 7,915,269; 7,935,731; 7,964,647; 7,964,648; 7,981,938; 8,093,296; 8,093,297; 8,097,655; 8,440,722 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Takeda Pharmaceuticals U.S.A. v. Hikma Americas Inc.
Details for Takeda Pharmaceuticals U.S.A. v. Hikma Americas Inc. (Fed. Cir. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2014-11-07 | External link to document | |||
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
